0 Bewertungen

ID

23655

Beschreibung

Study ID: 100480, 759346/004 & 100791 Clinical Study ID: 100480, 759346/004 & 100791 Study Title: Study to assess immunogenicity and non-inferiority of investigational vaccination regimen as compared to Tritanrix-HepB/Hiberix and as compared to Meningitec when administered to healthy infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine Trade Name: Tritanrix HepB/Hiberix Study Indication: Diphtheria; Haemophilus influenzae type b; Hepatitis B; Tetanus; Whole Cell Pertussis Documentation part: Non-Serious Adverse Events

Stichworte

  1. 10.07.17 10.07.17 -
  2. 04.05.18 04.05.18 - Sarah Riepenhausen
Hochgeladen am

10. Juli 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Investigational vaccination compared to Tritanrix-HepB/Hiberix and Meningitec Non-Serious Adverse Events 100480

    Non-Serious Adverse Events Investigational vaccination compared to Tritanrix-HepB/Hiberix and Meningitec 100480

    Non-serious Adverse Events
    Beschreibung

    Non-serious Adverse Events

    Alias
    UMLS CUI-1
    C1518404
    UMLS CUI-2
    C0042210
    Subject Number
    Beschreibung

    Subject Number

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C2348585
    Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
    Beschreibung

    If YES, please complete the following table.

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1518404
    Adverse Event Number
    Beschreibung

    Adverse Event Number

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1518404
    UMLS CUI [1,2]
    C0237753
    Non-serious adverse events: Description
    Beschreibung

    Description

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C0678257
    UMLS CUI [1,2]
    C1518404
    Non-serious adverse events: Description
    Beschreibung

    Description

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0678257
    UMLS CUI [1,2]
    C1518404
    Type of vaccine
    Beschreibung

    Description of Non-Serious Adverse Event

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0042210
    UMLS CUI [1,2]
    C0332307
    UMLS CUI [2,1]
    C1518404
    UMLS CUI [2,2]
    C0678257
    Start Date
    Beschreibung

    Start Date

    Datentyp

    date

    Alias
    UMLS CUI [1,1]
    C0808070
    UMLS CUI [1,2]
    C1518404
    Start: during immediate post-vaccination period (30 minutes)
    Beschreibung

    Start

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0439659
    UMLS CUI [1,2]
    C1518404
    End Date
    Beschreibung

    End Date

    Datentyp

    date

    Alias
    UMLS CUI [1,1]
    C0806020
    UMLS CUI [1,2]
    C1518404
    Maximum Intensity
    Beschreibung

    Maximum Intensity

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1710056
    UMLS CUI [1,2]
    C1518404
    Is there a reasonable possibility that the non-serious AE may have been caused by the investigational product(s)?
    Beschreibung

    Relationship to investigational product(s)

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0304229
    UMLS CUI [1,2]
    C0085978
    UMLS CUI [1,3]
    C1518404
    Outcome
    Beschreibung

    Outcome

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C1705586
    UMLS CUI [1,2]
    C1518404
    Medically attended visit?
    Beschreibung

    Medically attended visit

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0545082
    UMLS CUI [1,2]
    C1386497
    UMLS CUI [2]
    C1518404
    Medically attended visit type
    Beschreibung

    Did the subject seek medical advice? If yes, please specify type

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C0545082
    UMLS CUI [1,2]
    C0332307
    UMLS CUI [1,3]
    C1386497
    UMLS CUI [2]
    C1518404

    Ähnliche Modelle

    Non-Serious Adverse Events Investigational vaccination compared to Tritanrix-HepB/Hiberix and Meningitec 100480

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    Non-serious Adverse Events
    C1518404 (UMLS CUI-1)
    C0042210 (UMLS CUI-2)
    Subject Number
    Item
    Subject Number
    text
    C2348585 (UMLS CUI [1])
    Item
    Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
    integer
    C1518404 (UMLS CUI [1])
    Code List
    Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
    CL Item
    No (1)
    CL Item
    Yes, please complete the following table (2)
    Adverse Event Number
    Item
    Adverse Event Number
    integer
    C1518404 (UMLS CUI [1,1])
    C0237753 (UMLS CUI [1,2])
    Description
    Item
    Non-serious adverse events: Description
    text
    C0678257 (UMLS CUI [1,1])
    C1518404 (UMLS CUI [1,2])
    Item
    Non-serious adverse events: Description
    integer
    C0678257 (UMLS CUI [1,1])
    C1518404 (UMLS CUI [1,2])
    Code List
    Non-serious adverse events: Description
    CL Item
    Administration sites (1)
    CL Item
    Non-administration site (2)
    Item
    Type of vaccine
    integer
    C0042210 (UMLS CUI [1,1])
    C0332307 (UMLS CUI [1,2])
    C1518404 (UMLS CUI [2,1])
    C0678257 (UMLS CUI [2,2])
    Code List
    Type of vaccine
    CL Item
    Tritanrix-HepB/Hib-MenAC vaccine (1)
    CL Item
    Tritanrix-HepB/Hiberix vaccine (2)
    CL Item
    Meningitec vaccine (3)
    Start Date
    Item
    Start Date
    date
    C0808070 (UMLS CUI [1,1])
    C1518404 (UMLS CUI [1,2])
    Start
    Item
    Start: during immediate post-vaccination period (30 minutes)
    boolean
    C0439659 (UMLS CUI [1,1])
    C1518404 (UMLS CUI [1,2])
    End Date
    Item
    End Date
    date
    C0806020 (UMLS CUI [1,1])
    C1518404 (UMLS CUI [1,2])
    Item
    Maximum Intensity
    integer
    C1710056 (UMLS CUI [1,1])
    C1518404 (UMLS CUI [1,2])
    Code List
    Maximum Intensity
    CL Item
    Mild (1)
    CL Item
    Modearte (2)
    CL Item
    Severe (3)
    Relationship to investigational product(s)
    Item
    Is there a reasonable possibility that the non-serious AE may have been caused by the investigational product(s)?
    boolean
    C0304229 (UMLS CUI [1,1])
    C0085978 (UMLS CUI [1,2])
    C1518404 (UMLS CUI [1,3])
    Item
    Outcome
    text
    C1705586 (UMLS CUI [1,1])
    C1518404 (UMLS CUI [1,2])
    Code List
    Outcome
    CL Item
    Recovered / Resolved (1)
    CL Item
    Recovering / resolving (2)
    CL Item
    Not recovered / not resolved (3)
    CL Item
    Recovered with sequelae / Resolved with sequelae (4)
    Medically attended visit
    Item
    Medically attended visit?
    boolean
    C0545082 (UMLS CUI [1,1])
    C1386497 (UMLS CUI [1,2])
    C1518404 (UMLS CUI [2])
    Item
    Medically attended visit type
    text
    C0545082 (UMLS CUI [1,1])
    C0332307 (UMLS CUI [1,2])
    C1386497 (UMLS CUI [1,3])
    C1518404 (UMLS CUI [2])
    Code List
    Medically attended visit type
    CL Item
    Hospitalisation (HO)
    CL Item
    Emergency room (ER)
    CL Item
    Medical doctor (MD)

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video